1 Launching Defeating MS Together The European Code of Good Practice in MS Dr Alexis Willett & Prof Gavin Giovannoni
2 Outline 1. Background 2. Activity since the original Code 3. Revision process 4. Key features of Defeating MS Together 5. Next steps
3 Background Over 600,000 people living with MS - yet the treatment and support varies widely. Many people with MS are missing out on the vital care. The European Code of Good Practice in Multiple Sclerosis (Code) originally published in 2005 to highlight issues faced by people with MS and the measures needed to drive improvements. A landmark publication and tool. Since then, over nearly 10 years EMSP has worked with its members and European Parliament to create tools to transform the Code s principles into national policy and standards of practice.
4 Activity since the original Code A number key initiatives have been devised to support implementation at national level across the EU, including: Multiple Sclerosis Information Dividend (MS-ID) - MS Barometer High-level roundtables on MS European MS Register Pocket Guide
5 Why is the Code still needed? Despite progress: People with MS across EU still face wide variation in access to treatment and support as well as barriers to employment and benefits. We still need to better understand the initiation and progress of MS, including in those diagnosed as children, and how to effectively treat it. Taking action makes social and economic sense and is essential. The MS community across the EU alongside policy makers must work together in order to generate meaningful change.
6 Proportion of MSers eligible taking DMTs in the UK A lottery of treatment and care MS services across the UK ; MS Society April 2013.
7 Proportion of MSologists in the UK who use MRI to monitor for a response, or non-response, to DMTs? 26% 8% 26% 16% 24% No - never Yes - rarely Yes - occassionaly Yes - frequently Yes routinely
8 The Revision Process Dr Alexis Willett
9 Revision process 1. Briefing EMSP s broad vision 2. Consultation with EMSP stakeholders 3. Evidence review 4. Defeating MS Together developed Defeating MS Together: Main focus on policy makers action focused language, explanatory text, more quotes 12 Calls to Action, under 5 Action Areas and 1 Core Principle Timeline of Action
10 Defeating MS Together In Defeating MS Together: Current issues facing people with MS, and those who care for them, and set out clear calls to action aimed at improving their lives and reducing inequalities. Detailed Consensus Statements developed on key areas to provide best practice advice for the care and treatment of people with MS.
11 Calls to Action: Themes Core Principle: Empowering People with MS Action Area 1: Ensuring Access to MS Treatment, Therapies, Rehabilitation and Services Action Area 2: Better Understanding and Treatment of Pediatric MS Action Area 3: Focusing MS Research Action Area 4: Enabling Employment, Job Retention and Education Action Area 5: Supporting and Empowering MS Carers
12 Core Principle: Empowering People with MS Underpinning all the action areas - core principle and requirement to support and encourage the participation and empowerment of people with MS. Essential all people with MS, and their carers, are given opportunity to be involved in decision making about their treatment and care and to feed into research and policies. Need better partnerships between people with MS, the organisations that represent them, healthcare professionals, researchers, and policy makers.
13 Core Principle: Empowering People with MS Call 1: All those who work with people with MS, and their carers, should positively encourage their involvement and provide appropriate information and support to enable them to take part in decision-making that ultimately affects their lives. Call 2: All healthcare professionals must recognise the information needs of people with MS, and their carers, and provide honest and useful information about their condition, prognosis and treatment, therapies, rehabilitation and support available to them.
14 Action Area 1: Ensuring Access to MS Treatment, Therapies, Rehabilitation and Services Lack of access to treatment, therapies, rehabilitation and services severely diminishes quality of life, and can lead to missed opportunities to more effectively manage the progression of the disease. But - wide variation in access to optimal treatment and care across the EU. Role of MS nurse is diverse and varies across EU, leading to inequalities in patient access to care and advice.
15 Action Area 1: Ensuring Access to MS Treatment, Therapies, Rehabilitation and Services Call 3: All people with MS across the EU must be able to access the recommended treatments, therapies, rehabilitation and skilled, professional support. Call 4: Healthcare commissioners and providers across the EU must fully recognise the importance and value of MS nurses and ensure there are adequate numbers employed.
16 Action Area 2: Better Understanding and Treatment of Paediatric MS Approx 3 5% of MS patients experience first MS attack during childhood. There is a lack of research studies in paediatric MS. Paediatric MS displays different disease progression from adult onset MS - more research needed to better understand prognosis, treatment options and support needs for children and adolescents. Diagnosis of MS has a major impact on young patients and their families, so psychological and social support needed to assist them in facing the physical and psychological limitations in family, school and social activities.
17 Action Area 2: Better Understanding and Treatment of Paediatric MS Call 5: All children and adolescents with MS across the EU, and their families, must be able to access the recommended treatments and therapies and skilled, professional support. Call 6: Research funders must provide increased resources for, and researchers must design, more targeted clinical trials to identify the most effective treatments for children and adolescents with MS.
18 Action Area 3: Focusing MS Research Significant investment needed to find a cure, or identify effective symptomatic treatments or prevention mechanisms. A number of research priorities identified, incl: the epidemiology, genetics, and clinical pathology of MS, types of therapy, biomarkers and the better understanding of progressive forms of MS. At present no effective disease-modifying treatment available for progressive MS and no way to accurately and consistently predict progression or prevent it from happening. Overall impact of research efforts can be undermined by a lack of co-ordination between European countries.
19 Action Area 3: Focusing MS Research Call 7: The EU and other research funders must allocate particular attention and resources to research into progressive MS. Call 8: Researchers, research funders and MS organisations across Europe must collaboratively develop a series of shared research and data management strategies.
20 Action Area 4: Enabling Employment, Job Retention and Education Extent to which people with MS are disabled by their condition varies and extent to which individuals may wish and be able to work also varies. Many employers not experienced in managing fluctuating and unpredictable changes in the functioning of employees with MS. People with chronic diseases, such as MS, can face difficulties in accessing and taking part in education.
21 Action Area 4: Enabling Employment, Job Retention and Education Call 9: All employers and education providers must be aware of legislation and policies requiring the need to provide support for people with chronic conditions, such as MS, and take steps to ensure this provision for all those who need it. Call 10: All policy-makers and employers must recognise the need for greater flexibility within social, disability and workplace benefits to account for the fluctuating needs of people with relapsing remitting MS.
22 Action Area 5: Supporting and Empowering Carers Estimated that more than one million people are affected through their role as carers and family members of people with MS. Essential that carers are adequately supported in their role. The isolation of carers also needs recognition.
23 Action Area 5: Supporting and Empowering Carers Call 11: All those who work with people with MS and their carers must take the particular needs of carers into account and offer support where appropriate. Call 12: The MS community should develop and promote a resource (such as an online hub) enabling MS carers from across the EU to communicate with each other, share their experiences and develop a voice.
24 Timeline for Action
25 Next steps Hot of the press! Launch today Looking to all of you to help take the new Code to your countries and policy makers to spread the word and start taking action Distribution strategy Monitoring plan EMSP Annual Progress Check Let us all encourage people to: COMMIT. SUPPORT. ADVOCATE. ACT.
26 With thanks to The invaluable contribution of the people with MS, carers, health professionals, policy specialists, member societies and Advisory Group members that generously provided their ideas, expert opinion and advice on Defeating MS Together. The financial contribution, in the form of unconditional grants, from EMSP s corporate supporters that have enabled us to undertake the detailed research, consultation, development and production of Defeating MS Together.
CHANGING THE LANDSCAPE OF MS IN EUROPE Overview of the EMSP 2015-2020 Strategic Plan The Voice of People Living with MS in Europe The European Multiple Sclerosis Platform (EMSP) exists to improve the quality
Defeating MS Together The European Code of Good Practice in MS Contents 2 Foreword 8 Executive Summary 9 Timeline for Action 12 Monitoring Progress Multiple Sclerosis in Context 16 What is Multiple Sclerosis
Policy proposals to improve access to multiple sclerosis treatments in Europe Key findings and conclusions EMSP Conference Oslo, 17 May 2016 This research builds on a study conducted by CRA in 2014 There
EUROPEAN GUIDELINES FOR CANCER PATIENTS RIGHTS Edited by the ECL s European network on patients' and health professionals rights and duties Athens, 16 th October 2004 Preliminary considerations A diagnosis
Board of Member States ERN implementation strategies January 2016 As a result of discussions at the Board of Member States (BoMS) meeting in Lisbon on 7 October 2015, the BoMS set up a Strategy Working
MS Nurse PROfessional The first and only European accredited MS nurse training curriculum www.msnursepro.org Available in EIGHT languages This activity is supported by educational grants from: Founding
European Register for Multiple Sclerosis - a Tool to Assess, Compare and Enhance the Status of People with MS throughout the EU MILESTONES 2011 2012 Project co-funded by the Public Health Program of the
Prepared For: Biogen International GmbH Landis & Gyr-Strasse 3 6300 Zug, Switzerland Policy proposals to improve access to multiple sclerosis treatments in Europe Final report Prepared By: Tim Wilsdon,
EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES 24 OCTOBER 2011 INTRODUCTION 1. THE EUROPEAN CONTEXT Centres of expertise (CE) and European Reference
MS Barometer 2013 Widespread health inequalities revealed 0 P a g e About EMSP The European Multiple Sclerosis Platform (EMSP) represents more than 600,000 people living with multiple sclerosis (MS) in
The End of Life Care Strategy promoting high quality care for all adults at the end of life Prof Mike Richards July 2008 The End of Life Care Strategy: Rationale (1) Around 500,000 people die in England
COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9636/08 SAN 87 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY,
Welcome to the McPin Foundation About us: Thank you for your interest in our organisation and this Senior Researcher position. Our aim is to transform mental health research to place people affected by
MS-NEED: Multiple Sclerosis-Nurse Empowering Education European Multiple Sclerosis Platform Rehabilitation in Multiple Sclerosis International Organisation of Multiple Sclerosis Nurses Objectives of MS-NEED
Research and Development Strategy (DRAFT) 2013-2018 Research is everybody s business 1 Information Reader Box to be inserted for documents six pages and over. (To be inserted in final version, after consultation
Multiple sclerosis (MS) is a chronic, often disabling, disease that attacks the central nervous system, which is made up of the brain, spinal cord, and optic nerves. Symptoms may be mild or severe, ranging
Brochure More information from http://www.researchandmarkets.com/reports/2541548/ PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 Description: PharmaPoint: Multiple
Section 1: The purpose of this document There are three key components to the Healthcare Science workforce in the UK: 1. Healthcare Science Associates and Assistants who perform a diverse range of task
Parental mental health and child welfare: Review of professional education (summary) Nicky Stanley and Pat Cox The review questions To what extent do professional education bodies and workforce strategies
EURORDIS Position Paper on Centres of Expertise and European Reference Networks for Rare Diseases EURORDIS - the European Organisation for Rare Diseases represents 310 rare disease organisations from 34
NATIONAL INFORMATION BOARD Personalised Health and Care 2020 WORK STREAM 4 ROADMAP Build and sustain public trust Deliver roadmap to consent based information sharing and assurance of safeguards June 2015
RCN INTERNATIONAL DEPARTMENT Royal College of Nursing (UK) consultation response to the European Commission s Green Paper on the European Workforce for Health. With a membership of just under 400,000 registered
Mellen Center Cleveland Clinic Marie Namey, RN, MSN, MSCN Mellen Center Cleveland Clinic Cleveland, OH Home of. Mellen Center for Multiple Sclerosis Mellen Center Mission The Mellen Center remains committed
EV ENT REPORT SUMMARY: SUPPORT ING PEOPL E W IT H MS IN EMPLOYMENT?We need to work together. But not only institutions with EU member states, we also need civil society and NGOs. You are the ones who keep
THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges
Improving patient care through better general practice and community pharmacy integration A consultation document August, 2015 Purpose of this consultation Improving patient care poses a significant challenge
Research Strategy 2012 2020 Foreword Acknowledgements We are particularly indebted to Professor David Neal and Professor Michael Olson for their expert assessment of the trends, gaps and bottlenecks in
Leading cancer treatments and improving outcomes for patients: Our Why? Our patients will always come first and no matter what our vision is for the years ahead, this ethos of will always remain the same.
Overview of the Department The Liverpool Clinical Academic Department of Paediatric Rheumatology is based at Alder Hey Children s NHS Foundation Trust and in the Institute of Child Health, University of
Calendar of events 2016 NEUROLOGY Rome, Italy 29 January 2016 Updates on MS treatment management Project an individualized treatment plan in MS Explain how to manage patients day to day issues List the
JOB DESCRIPTION ellenor Advanced Nurse Practitioner Specialist Palliative Care Responsible to Accountable to: Head of Adult Community Services Director of Patient Care General ellenor is a specialist palliative
Brain & CNS cancers 2015 Annex B Epidemiology 1. The incidence of brain & CNS tumours in England was reported to be just under 4,000 in 2007. 1 This is expected to increase further with an aging population
Public Bodies (Joint Working) (Scotland) Bill The Coalition of Carers in Scotland Do you agree with the general principles of the Bill and its provisions? Last year we held a series of consultation events
Delivery models from 14 Regions in Europe Upscaling Telehealth - the need for policy engagement 1 Professor George Crooks OBE MBChB FRCP FRCGP Medical Director NHS 24 This version of the document is subject
MULTIPLE SCLEROSIS PHYSICIAN RESOURCES This resource provides internet links that may be of interest to your patients diagnosed with multiple sclerosis. Many of these links will provide invaluable information
PRACTICE FRAMEWORK AND COMPETENCY STANDARDS FOR THE PROSTATE CANCER SPECIALIST NURSE MARCH 2013 MONOGRAPHS IN PROSTATE CANCER OUR VISION, MISSION AND VALUES Prostate Cancer Foundation of Australia (PCFA)
Overcoming cancer with research Vienna 15 th -17 th May, 2008 Session 3: Established therapeutic compounds Introduction Randomized clinical trials: bedrock of progress in children with cancer in the last
MS Priority Setting Partnership Voting for your top research questions Survey Prioritising important research questions for multiple sclerosis a partnership between people affected by MS and healthcare
Proposed co-location of stroke services Contents Contents... 2 Executive summary... 3 Introduction... 4 How stroke services are currently provided... 6 The case for change... 8 What is our proposed service
CLINICAL RESEARCH NETWORK Introduction The vision of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. This document sets out how the
Research and Innovation Strategy: delivering a flexible workforce receptive to research and innovation Contents List of Abbreviations 3 Executive Summary 4 Introduction 5 Aims of the Strategy 8 Objectives
National Institute for Health and Care Excellence NICE Quality Standards Consultation Idiopathic Pulmonary Fibrosis Closing date: 5pm Tuesday 23 September 2014 Organisation Title Name Job title or role
Health Consumers Queensland...your voice in health Consumer and Community Engagement Framework February 2012 Definitions In this Framework, Health Consumers Queensland utilises the following definitions
The National Health Plan for Young Australians An action plan to protect and promote the health of children and young people Copyright 1997 ISBN 0 642 27200 X This work is copyright. It may be reproduced
A Health and Wellbeing Strategy for Bexley Listening to you, working for you www.bexley.gov.uk Introduction FOREWORD Health and wellbeing is everybody s business, and our joint aim is to improve the health
Dorset CCG Clinical Services Review PUBLIC INFORMATION EVENT FEBRUARY 2015 Why are we doing a Clinical Services Review in Dorset? NHS Dorset Clinical Commissioning Group (CCG) wants to ensure that everybody
Population Health Research Strategy 2012-2015 Population Health Division ACT Health 1. Foreword The shift in policy direction towards prevention and early intervention, and the associated funding for preventive
POSITION DESCRIPTION POSITION TITLE Health Independence Program Speech Pathologist Speech Pathologist Grade 2 REPORTS TO: Manager Health Independence Programs & Health and Rehabilitation Centre Professionally
Nursing For Health A REVIEW OF THE CONTRIBUTION OF NURSES, MIDWIVES AND HEALTH VISITORS TO IMPROVING THE PUBLIC S HEALTH Working together for a healthy, caring Scotland Nursing for Health A REVIEW OF THE
Directive 2011/24/EU on the application of patients rights in cross-border healthcare EPF for a patient-centred implementation Introduction These recommendations have been developed by the European Patients
Individual-Level Data Collection From Specialist Palliative Care Individual-level data collection from specialist palliative care About Public Health England Public Health England exists to protect and
State of Mississippi Oral Health Plan 2006 2010 Vision Statement: We envision a Mississippi where every child enjoys optimal oral health; where prevention and health education are emphasized and treatment
Women in Europe Towards Healthy Ageing Hildrun Sundseth European Institute of Women s Health About the EIWH The European Institute of Women s Health is a health NGO launched in 1996 The EIWH aims to ensure
Mission The NWFED is an independent membership body, bringing museum people together across the North West region. NWFED Business Plan 2015-18 The NWFED supports professionals, volunteers and people who
535 REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN PSYCHO-ONCOLOGY (PDipPsycho-oncology) (See also General Regulations) M.105 Admission requirements To be eligible for admission to the programme leading to
Understanding Multiple Sclerosis Tim, diagnosed in 2004. What Is Multiple Sclerosis? Multiple sclerosis (MS) is a neurologic disorder that affects the central nervous system (CNS). The CNS includes the
NICE: REHABILITATION AFTER STROKE GUIDELINE Sue Thelwell Stroke Services Co-ordinator UHCW NHS Trust Content About me! NICE Rehabilitation after Stroke to include background, remit and scope, guideline
National Clinical Programmes Section 3 Background information on the National Clinical Programmes Mission, Vision and Objectives July 2011 V0. 6_ 4 th July, 2011 1 National Clinical Programmes: Mission
PNAE Paediatric Nursing Associations of Europe Paediatric Nurse Education in Europe A Position Statement by the Paediatric Nursing Associations of Europe (PNAE) Introduction The PNAE network carried out
A CHECK-LIST FOR NATIONAL STRATEGIES TO END CHILD MARRIAGE February 2016 1 x?......... A CHECK-LIST FOR NATIONAL STRATEGIES TO END CHILD MARRIAGE February 2016 Every year 15 million girls are married before
ehealth in support of safety, quality and continuity of care within and across borders Gerard Comyn Acting Director Information Society & Media DG European Commission http://europa.eu.int/information_society/activities/health/index_en.htm
A Competency Based Curriculum for Specialist Training in Psychiatry Specialist Module in Old Age Psychiatry Royal College of Psychiatrists Royal College of Psychiatrists 2009 SPECIALIST IN THE PSYCHIATRY
Biogen Global Medical Grants Office Multiple Sclerosis: Areas of Interest Cycle C June 2, 2015 1 Introduction The landscape for the treatment of relapsing Multiple Sclerosis (MS) has quickly evolved over
Department for Business Innovation & Skills: Review of the EU Balance of Competences: Research and Development Response by the Wellcome Trust Key Points Effective engagement with the European Union (EU)
Putting the Cart Back Behind the Horse: Converting a population based research database into an electronic clinical patient record The Story Crash course on Multiple Sclerosis A little bit of History of
19 September 2014 Open BD.2014.09.19.10 Treat Me Right campaign Ian Fannon Head of Communications and Campaigns John Palmer Executive Director of Marketing and Communications Nick Rijke Executive Director
Bologna 15 Dicembre 2014 ERA-Net COFUND Research Programmes on Rare Diseases (E-RARE) The Role of RER-ASSR Antonio Addis Research Governance Area Agenzia Sanitaria e Sociale Regionale How do Regions might
Health LEADS Australia: the Australian health leadership framework July 2013 Health Workforce Australia. This work is copyright. It may be reproduced in whole for study purposes. It is not to be used for
Conference: Analysing how to reduce the Access Barriers to Health Care for People with Chronic Diseases in Europe Challenges, good practices and policy options for people with rheumatic and musculoskeletal
Understanding series LUNG CANCER CLINICAL TRIALS 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS The Basics What is a Clinical Trial?...3 Types of Clinical Trials... 3 Phases
Helping children get the care experience they need Independent advocacy for children and young people in care May 2016 Introduction Professionals are often required to make lifechanging decisions for children
Eucomed Six Key Principles for the Efficient and Sustainable Funding & Reimbursement of Medical Devices Contents Executive Summary 2 Introduction 3 1. Transparency 4 2. Predictability & Consistency 5 3.
HWB5 Level 4 RCN Competences Core competences for nursing children and young people 1 RCN Legal Disclaimer This publication contains information, advice and guidance to help members of the RCN. It is intended
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Workplace health: support for employees with disabilities and long-term conditions Short title Workplace health: employees with disabilities
The Stroke Strategy confirmed that the Department would commission a short analysis of research evidence in relation to the strategy and the top ten research areas identified in it. We said that we would
POSITION PAPER 21 April 2011 Rev. 15 September 2011 Overcoming barriers to ehealth Page 1 of 5 What is ehealth? Information and Communication Technology (ICT) has changed the way people carry out a broad
WORKING DIFFERENTLY WORKING TOGETHER A WORKFORCE AND ORGANISATIONAL DEVELOPMENT FRAMEWORK 1 Printed on recycled paper Print ISBN 978 0 7504 7415 3 Digital ISBN 978 0 7504 7416 0 Crown copyright 2012 WG
1 Position Statement: National Disability Insurance Scheme Multiple Sclerosis Australia (MSA) Position: People affected by MS, including their families and carers should have access to the type and level
The Health and Social Care Act 2012 introduced significant amendments to the NHS Act 2006, especially with regard to how NHS commissioners will function. These amendments include two complementary duties
Strategic Plan 2013-2017 2 P age Presidents Welcome It is my great pleasure to present the European Federation of Periodontology s strategy for 2013-2017. This is the European Federation of Periodontology
Role Description Job ad reference: RK6B204896 Hospital and Health Service: Role title: Allied Health Senior (Clinical Intake Officer) Status: Permanent Part Time (38 hrs p.f.) Unit: Child Development Services